Kynurenic acid attenuates experimental allergic rhinitis: Evidence for AhR-associated regulation of mucosal immune homeostasis
PLOS One · 2026
DOI: 10.1371/journal.pone.0359624 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Naim Gheymoumi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alborz University of Medical Sciences, Karaj, Iran. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Rhinitis, Allergic, Kynurenic Acid, Homeostasis. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alborz University of Medical Sciences.
Abstract (Originalsprache)
Background
Allergic rhinitis (AR) is a chronic inflammatory airway disease characterized by dysregulated type 2 immune responses and impaired mucosal immune regulation. Kynurenic acid (KYNA), an endogenous tryptophan metabolite with immunomodulatory properties, may influence inflammatory pathways, but its mechanisms in AR remain unclear. This study investigated KYNA in an ovalbumin (OVA)-induced rat model of AR and examined the role of aryl hydrocarbon receptor (AhR) signaling.
Methods
Rats were assigned to control, AR, vehicle, KYNA, desloratadine, and KYNA + AhR antagonist (CH223191) groups. Following OVA sensitization and challenge, behavioral responses, serum inflammatory markers, nasal AhR-associated proteins, regulatory cytokines, and histopathological changes in nasal and splenic tissues were evaluated.
Results
OVA induced typical allergic responses, including increased sneezing and nasal scratching, elevated serum IgE, IL-4, and IL-6, and marked inflammatory changes in nasal and splenic tissues. KYNA significantly reduced behavioral symptoms, systemic inflammatory mediators, epithelial damage, and inflammatory infiltration, with systemic effects comparable to desloratadine but greater improvement in nasal scratching and splenic histopathology. KYNA restored nasal AhR and CYP1A1 expression and increased IL-10 and TGF-β, whereas CH223191 partially attenuated these effects, indicating involvement of AhR signaling. Desloratadine showed limited effects on local regulatory cytokines. Histopathological analysis confirmed improved nasal and splenic architecture following KYNA treatment.
Conclusion
In conclusion, KYNA attenuates experimental AR through systemic anti-inflammatory effects and restoration of mucosal immune regulation. AhR signaling contributes to these effects, particularly in CYP1A1 and cytokine regulation, while additional mechanisms may also be involved. These findings support KYNA as a potential immunometabolic modulator in allergic airway disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alborz University of Medical Sciences, Karaj, Iran.
- Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran.
ORCID-Profile: Sevda Shayesteh, Fatemeh Sharifi
Förderung
- Alborz University of Medical Sciences
Zitieren
APA
Gheymoumi, N., Shayesteh, S., Sharifi, F., Amiri-Andebili, M., & Gheymoumi, H. (2026). Kynurenic acid attenuates experimental allergic rhinitis: Evidence for AhR-associated regulation of mucosal immune homeostasis. PLOS One. https://doi.org/10.1371/journal.pone.0359624
Vancouver
Gheymoumi N, Shayesteh S, Sharifi F, Amiri-Andebili M, Gheymoumi H. Kynurenic acid attenuates experimental allergic rhinitis: Evidence for AhR-associated regulation of mucosal immune homeostasis. PLOS One. 2026. doi:10.1371/journal.pone.0359624
BibTeX
@article{Gheymoumi2026,
author = {Gheymoumi, Naim and Shayesteh, Sevda and Sharifi, Fatemeh and Amiri-Andebili, Marziyeh and Gheymoumi, Hediyeh},
title = {Kynurenic acid attenuates experimental allergic rhinitis: Evidence for AhR-associated regulation of mucosal immune homeostasis},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0359624}
}
EUVIMED